The global genomics market is anticipated to witness a significant CAGR during the forecast period, 2019 – 2026. Medical advances in genomics technologies have shaped the life sciences market which in turn is accelerating the use of genomics.
Genomics is an evolving field wherein massive changes on technological front enables researchers to combine massive pieces of human genome. Research in genomics initiated in the early 80s following the development in polymerase chain reaction that allowed scientists and researchers to illustrate the genome at an individual level. In the past two decades owing to the widening scope of gene study in humans and clinical research, next generation sequencing (NGS) has resulted in a cost decline. This approach in return alters the genomics research and opens new avenues to clinical genomics. Genomic techniques are widely used in the clinical settings and have influenced the study of infectious disease, inherited disease and cancer by conducting a meta-analysis on new analytes and enhancing the turnaround time as compared to conventional approach.
Request a sample Report of Genomics Market @https://dataintelo.com/request-sample/?reportId=503
There are certain trends that the market is expected to observe in 2020. i.e. high acceptance for NGS, shift to single-cell biology, high emergence of RNA biology, determining the magnitude of research experiment and a vast use of genotype and phenotype. Analyzing each and every trend leads in understanding the potential of lucrative opportunities of medical companies, clinics and life science researchers. Therefore, the industry development is highly dependent on the strategies and active participation of these factors.